S100A9 and rheumatoid arthritis: The calgranulins, specifically S100A8 and S100A9, have been implicated in both rheumatoid arthritis and OA and are considered potent damage-associated molecules which exacerbate inflammation following their release under conditions of cellular stress or injury [35, 36].